Skip to main contentAI and Advanced
/
INNOVACAP · NSEMarket ticker unavailable · configure an authorised index feed
IN
NSE · Equity shares · Biotechnology & Drugs12.00 · 1.06%
Innova Captab INNOVACAP
NSE:INR 1,145
BSE:INR 960
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for INNOVACAP
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,133
Day rangeINR 1,080.2 — INR 1,164.9
52-week rangeINR 622 — INR 1,236.1
Volume1.19 L
Market cap5,461.18
P/E28.01
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,630.02
Net Income (INR Cr)140.92
Rev Growth (5 Year %)31.75
EPS Growth (5 Year %)27.93
P/E Ratio28.01
Book Value187.44
EPS24.53
Price/BV6.11Computed
Research path: Interpret Innova Captab's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
INNOVACAPInnova Captab1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,837.38 | 1,580.41 | 1,320.88 |
| Accumulated Depreciation Total | -111.75 | -68.39 | -46.04 |
| Other Liabilities Total | 11.92 | 9.91 | 9.14 |
| Accrued Expenses | 23.98 | 18.09 | 13.66 |
| Long Term Debt | 214.8 | 243.55 | 208.2 |
| Common Stock Total | 57.23 | 57.23 | 57.23 |
| Other Current Assets Total | 7.1 | 9.4 | 8.56 |
| Prepaid Expenses | 3.34 | 2.77 | 3.42 |
| Total Assets | 1,837.38 | 1,580.41 | 1,320.88 |
| Current Portof LT Debt/Capital Leases | 28.61 | 27.58 | 10.74 |
| Additional Paid-In Capital | 379.23 | 377.73 | 377.73 |
| Cash | 3.2 | 15.52 | 11.73 |
| Total Equity | 1,090.79 | 959.42 | 830.89 |
| Long Term Investments | 36.92 | 5.75 | 0 |
| Retained Earnings(Accumulated Deficit) | 654.34 | 524.19 | 394.05 |
| Total Common Shares Outstanding | 5.72 | 5.72 | 5.72 |
| Property/Plant/Equipment Total-Gross | 950.59 | 902.59 | 727.12 |
| Tangible Book Valueper Share Common Eq | 187.44 | 164.61 | 142.12 |
| Goodwill Net | 16.69 | 16.69 | 16.69 |
| Total Liabilities | 746.59 | 620.99 | 489.99 |
| Total Debt | 343.69 | 338.12 | 245.1 |
| Short Term Investments | 65.05 | 49.76 | 72.36 |
| Cashand Short Term Investments | 68.25 | 65.28 | 84.09 |
| Total Receivables Net | 554.53 | 406.75 | 337.1 |
| Notes Payable/Short Term Debt | 99.26 | 65.65 | 23.84 |
| Deferred Income Tax | 24.27 | 13.19 | 4.84 |
| Accounts Receivable-Trade Net | 439.24 | 332.01 | 289.73 |
| Property/Plant/Equipment Total-Net | 838.84 | 834.95 | 681.08 |
| Total Current Liabilities | 494.58 | 353 | 265.48 |
| Total Inventory | 289.74 | 211.5 | 146.58 |
| Accounts Payable | 318.63 | 201.8 | 179.66 |
| Other Currentliabilities Total | 24.1 | 39.88 | 37.58 |
| Total Long Term Debt | 215.82 | 244.89 | 210.52 |
| Intangibles Net | 1.48 | 0.74 | 0.9 |
| Other Long Term Assets Total | 7.61 | 22.35 | 22.9 |
| Note Receivable-Long Term | 12.88 | 4.23 | 19.55 |
| Total Current Assets | 922.96 | 695.69 | 579.75 |
| Capital Lease Obligations | 1.02 | 1.35 | 2.32 |
| Other Equity Total | Not available | 0.27 | 1.89 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.89
Price to Sale Ratio3.35
Growth
Debt 5Yr CAGR %49.84
Margins
Operating Margin 12m11.86
Operating Margin 5y Avg11.69
Net Profit Margin 12m8.65
Net Profit Margin 5y8.72
Yield
Dividend Yield %0.21
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk34.46
Analyst consensus
ConsensusBuy
Consensus score2.00
Analyst opinions2
Strong Sell count0
Sell count0
Hold count0
Buy count2
Strong Buy count0
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,944 | 4.66 L | 38.4 | — |
| Divi's Laboratories | INR 8,291.55 | 2.20 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,965 | 1.89 L | 72.73 | — |
| Cipla | INR 1,475 | 1.19 L | 27.57 | — |
| Zydus Lifesciences | INR 1,106.25 | 1.10 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 50.90%
- FII
- 0.34%
- MF
- 9.18%
- Other
- 39.58%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Broad-Based Technical Strength Lifts Innova Captab Ltd to 52-Week High of Rs 1032.25 - MarketsMojoMarket news · 15 Jul 2026, 10:20 am
Broad-Based Technical Strength Lifts Innova Captab Ltd to 52-Week High of Rs 1032.25 MarketsMojo
Innova Captab Ltd is Rated Hold by MarketsMOJO - MarketsMojoMarket news · 13 Jul 2026, 11:24 am
Innova Captab Ltd is Rated Hold by MarketsMOJO MarketsMojo
Price to book forward of Innova Captab Limited – NSE:INNOVACAP - TradingViewMarket news · 13 Jul 2026, 3:16 am
Price to book forward of Innova Captab Limited – NSE:INNOVACAP TradingView
Innova Captab Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility - MarketsMojoMarket news · 10 Jul 2026, 8:24 am
Innova Captab Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility MarketsMojo
Number of shareholders of Innova Captab Limited – NSE:INNOVACAP - TradingViewMarket news · 8 Jul 2026, 6:46 am
Number of shareholders of Innova Captab Limited – NSE:INNOVACAP TradingView
Innova Captab Ltd Technical Momentum Shifts Amid Mixed Market Signals - MarketsMojoMarket news · 7 Jul 2026, 8:08 am
Innova Captab Ltd Technical Momentum Shifts Amid Mixed Market Signals MarketsMojo
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsAudited Results
- dividendRs.2.0000 per share(20%)Interim Dividend
- board MeetingsTo consider other business matters.
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsAudited Results
Rusaka Markets Community
Discussion and sentiment for Innova Captab
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Innova Captab Limited is an India-based integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- INNOVACAP
- BSE Code
- 544067
Questions
Stock FAQ
What is the symbol and ISIN of Innova Captab?
Innova Captab has the symbol INNOVACAP and ISIN - INE0DUT01020.
What is the current price of Innova Captab?
Innova Captab is currently trading at INR 1,145.00.
What are the year high and year low of Innova Captab?
Innova Captab has a year high of INR 1,236.10 and a year low of INR 622.00.
What is the market capitalization of Innova Captab?
Innova Captab has a market capitalization of INR 5,461.18 crore.
What is the P/E ratio of Innova Captab?
Innova Captab has a P/E ratio of 28.01.
What is the dividend yield of Innova Captab?
Innova Captab has a dividend yield of 0.21%.
How is the financial performance of Innova Captab based on revenue, net income, and EPS?
Innova Captab has revenue of INR 1,630.02 crore, net income of INR 140.92 crore, and EPS of INR 24.63.
What is the book value of Innova Captab?
Innova Captab has a book value of INR 187.44.
What is the debt-to-equity ratio of Innova Captab?
Innova Captab has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Innova Captab?
Innova Captab has a price-to-book ratio of 6.11 and a price-to-sales ratio of 3.35.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.